16:33 - 29.07.2021
July 29, Fineko/abc.az. American pharmaceutical company Pfizer has raised the forecast of sales revenue that they will receive this year from vaccine against a new type of coronavirus (Covid-19), developed by German company BioNTech, from $26 bn up to $33.5 bn.
ABC.AZ reports that in May Pfizer announced that it plans to earn $26 bn this year from sales of vaccines.
According to the company, Pfizer's revenue in the 2nd quarter of this year (Apr-Jun) increased by 92% (versus same term of 2020) up to $19 bn.
Company's sales for the same period of 2020 amounted to $9.9 bn.
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
19 April 2024
18 April 2024
18 April 2024
18 April 2024
18 April 2024
18 April 2024
18 April 2024
17 April 2024
19 April 2024
17 April 2024
17 April 2024
17 April 2024